The mushrooming of the psychedelic renaissance: A scoping review identifying trends in ongoing clinical trials

Lucas M Wittenkeller, Gary Gudelsky, T. John Winhusen, Davide Amato

Research Square January 12, 2026 Peer reviewed DOI: 10.21203/rs.3.rs-8544354/v1 via OpenAlex

Relevant Not relevant

Abstract

No abstract available from the source.

Tags

Clinical trial Blinding Intervention counseling Alternative medicine Clarity

Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
Psilocybin for depression: Considerations for clinical trial design Journal of Psychedelic Studies • September 1, 2019 • via OpenAlex
Blinding Integrity in Psychedelic Randomized Clinical Trials JAMA Psychiatry • April 15, 2026 • via OpenAlex
Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial February 23, 2026 • via OpenAlex
It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial Palliative & Supportive Care • January 1, 2026 • via OpenAlex

Comments

No comments yet.

Log in to comment